MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
RPRX Royalty Pharma
- 24.920
- +0.640+2.64%
Close Dec 20 16:00 ET
- 25.010
- +0.090+0.36%
Post 20:01 ET
11.07BMarket Cap9.81P/E (TTM)
25.000High24.315Low7.57MVolume24.340Open24.280Pre Close188.55MTurnover1.95%Turnover Ratio9.85P/E (Static)444.30MShares30.92252wk High1.61P/B9.66BFloat Cap24.05052wk Low0.83Dividend TTM387.82MShs Float51.220Historical High3.33%Div YieldTTM2.82%Amplitude24.050Historical Low24.892Avg Price1Lot Size
Royalty Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 4.78%1.76B | -12.20%2.55B | -40.79%1.53B | -49.18%1.23B | -49.18%1.23B | -24.04%1.68B | -14.50%2.91B | -11.10%2.59B | -13.39%2.43B | -13.39%2.43B |
| -Cash and cash equivalents | 1.45%950.05M | -18.80%1.76B | -57.33%843M | -72.12%477.01M | -72.12%477.01M | -5.56%936.45M | 3.09%2.17B | 10.28%1.98B | 11.01%1.71B | 11.01%1.71B |
| -Short-term investments | 8.94%814.27M | 7.29%788.6M | 12.56%689.48M | 5.54%756.74M | 5.54%756.74M | -38.99%747.46M | -43.17%735.01M | -45.30%612.52M | -43.19%717.04M | -43.19%717.04M |
| Receivables | -34.32%24.9M | -33.06%23.58M | -42.18%22.23M | 0.14%36.65M | 0.14%36.65M | 8.81%37.91M | -0.34%35.23M | -41.59%38.44M | -46.42%36.6M | -46.42%36.6M |
| -Other receivables | -34.32%24.9M | -33.06%23.58M | -42.18%22.23M | 0.14%36.65M | 0.14%36.65M | 8.81%37.91M | -0.34%35.23M | -41.59%38.44M | -46.42%36.6M | -46.42%36.6M |
| Other current assets | -26.75%4.97M | -77.58%2.29M | 9.63%5.01M | -95.80%3.8M | -95.80%3.8M | -92.51%6.78M | -84.77%10.22M | -15.18%4.57M | 1,265.10%90.52M | 1,265.10%90.52M |
| Total current assets | 3.79%1.79B | -12.68%2.58B | -40.72%1.56B | -50.13%1.27B | -50.13%1.27B | -26.19%1.73B | -15.71%2.95B | -11.78%2.63B | -11.23%2.55B | -11.23%2.55B |
| Non current assets | ||||||||||
| Investments and advances | 14.88%16.21B | 6.45%15.05B | 1.05%14.57B | 6.13%15.1B | 6.13%15.1B | -7.80%14.11B | -0.45%14.14B | 0.15%14.41B | -2.73%14.23B | -2.73%14.23B |
| Other non current assets | 111.70%42.79M | -6.30%27.56M | -83.99%4.49M | -77.99%6.52M | -77.99%6.52M | -33.98%20.21M | -11.98%29.41M | 624.29%28.03M | 614.81%29.63M | 614.81%29.63M |
| Total non current assets | 15.01%16.25B | 6.42%15.08B | 0.89%14.57B | 5.96%15.11B | 5.96%15.11B | -7.85%14.13B | -0.48%14.17B | 0.32%14.44B | -2.59%14.26B | -2.59%14.26B |
| Total assets | 13.79%18.04B | 3.13%17.66B | -5.52%16.13B | -2.57%16.38B | -2.57%16.38B | -10.28%15.86B | -3.49%17.12B | -1.75%17.07B | -4.01%16.81B | -4.01%16.81B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -12.25%101.2M | 2.75%121.96M | -2.17%102.96M | -4.27%98.32M | -4.27%98.32M | -5.34%115.34M | -7.39%118.69M | -14.21%105.24M | -9.55%102.71M | -9.55%102.71M |
| -accounts payable | 61.85%22.06M | 303.10%23.42M | 73.52%11.55M | 91.82%15.17M | 91.82%15.17M | -15.42%13.63M | -52.29%5.81M | -0.08%6.66M | 40.68%7.91M | 40.68%7.91M |
| -Dividends payable | -22.18%79.15M | -12.70%98.54M | -7.28%91.41M | -12.29%83.16M | -12.29%83.16M | -3.80%101.71M | -2.68%112.88M | -15.02%98.58M | -12.17%94.8M | -12.17%94.8M |
| Current accrued expenses | 204.98%38.41M | 3.86%56.25M | -4.58%12.6M | -4.58%51.68M | -4.58%51.68M | -4.58%12.6M | 0.00%54.16M | 0.00%13.2M | -6.13%54.16M | -6.13%54.16M |
| Current debt and capital lease obligation | --996.94M | ---- | ---- | ---- | ---- | ---- | --999.37M | --998.44M | --997.51M | --997.51M |
| -Current debt | --996.94M | ---- | ---- | ---- | ---- | ---- | --999.37M | --998.44M | --997.51M | --997.51M |
| Other current liabilities | --31.2M | --97.49M | --9.02M | -8.27%11.38M | -8.27%11.38M | ---- | ---- | ---- | --12.4M | --12.4M |
| Current liabilities | 812.79%1.17B | -76.48%275.7M | -88.85%124.57M | -86.17%161.38M | -86.17%161.38M | -88.69%127.93M | 542.92%1.17B | 722.01%1.12B | 581.33%1.17B | 581.33%1.17B |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 7.82%6.61B | 24.07%7.6B | 0.27%6.14B | 0.27%6.14B | 0.27%6.14B | 0.27%6.13B | -13.78%6.13B | -13.78%6.12B | -13.77%6.12B | -13.77%6.12B |
| -Long term debt | 7.82%6.61B | 24.07%7.6B | 0.27%6.14B | 0.27%6.14B | 0.27%6.14B | 0.27%6.13B | -13.78%6.13B | -13.78%6.12B | -13.77%6.12B | -13.77%6.12B |
| Other non current liabilities | -50.62%5.58M | 218.13%27.04M | -73.82%3.22M | -64.00%900K | -64.00%900K | --11.3M | 4.94%8.5M | --12.3M | --2.5M | --2.5M |
| Total non current liabilities | 7.71%6.62B | 24.34%7.63B | 0.12%6.14B | 0.24%6.14B | 0.24%6.14B | 0.29%6.14B | -14.19%6.14B | -13.60%6.14B | -13.74%6.12B | -13.74%6.12B |
| Total liabilities | 24.13%7.78B | 8.17%7.9B | -13.58%6.27B | -13.59%6.3B | -13.59%6.3B | -13.59%6.27B | -0.33%7.31B | 0.21%7.25B | 0.29%7.29B | 0.29%7.29B |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%108K | -0.92%108K | 0.00%108K | 0.93%108K | 0.93%108K | 0.93%108K | 1.87%109K | 1.89%108K | 0.94%107K | 0.94%107K |
| -common stock | 0.00%108K | -0.92%108K | 0.00%108K | 0.93%108K | 0.93%108K | 0.93%108K | 1.87%109K | 1.89%108K | 0.94%107K | 0.94%107K |
| Retained earnings | 29.51%2.76B | 5.56%2.38B | 9.50%2.43B | 28.14%2.52B | 28.14%2.52B | -14.78%2.13B | -7.90%2.25B | -0.35%2.22B | -12.88%1.96B | -12.88%1.96B |
| Paid-in capital | 2.52%4.11B | 1.72%4.1B | 8.96%4.07B | 9.42%4.01B | 9.42%4.01B | 10.29%4.01B | 12.90%4.03B | 5.54%3.74B | 4.52%3.67B | 4.52%3.67B |
| Less: Treasury stock | 1.26%2.66M | 1.22%2.66M | -6.15%2.65M | -6.31%2.63M | -6.31%2.63M | -5.88%2.62M | -4.47%2.63M | 3.36%2.83M | 3.35%2.81M | 3.35%2.81M |
| Gains losses not affecting retained earnings | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 |
| Total stockholders'equity | 11.91%6.87B | 3.10%6.48B | 9.17%6.5B | 15.96%6.53B | 15.96%6.53B | -0.21%6.14B | 4.22%6.28B | 3.05%5.95B | -2.57%5.63B | -2.57%5.63B |
| Noncontrolling interests | -1.67%3.39B | -7.26%3.28B | -13.04%3.36B | -8.71%3.56B | -8.71%3.56B | -19.19%3.45B | -19.38%3.53B | -11.37%3.87B | -12.85%3.9B | -12.85%3.9B |
| Total equity | 7.03%10.26B | -0.63%9.75B | 0.42%9.86B | 5.87%10.08B | 5.87%10.08B | -7.98%9.59B | -5.71%9.81B | -3.15%9.82B | -7.06%9.53B | -7.06%9.53B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.